Skip to main content
. 2016 Jan 17;7(8):9007–9016. doi: 10.18632/oncotarget.6928

Figure 4. Cryab overexpression was associated with the poor prognosis of OS Patients.

Figure 4

A. Immunoreactivity of Cryab protein was located in the cytoplasm of the carcinoma cells (bar = 200μm); B. Prognostic significance assessed by Kaplan-Meier survival estimates and log-rank tests. Comparisons of OS and RFS by Cryab.